Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis

Amorim, Camila Farias; Novais, Fernanda Oliveira; Nguyen, Ba T.; Misic, Ana M.; Carvalho, Lucas Pedreia; Carvalho, Edgar Marcelino de; Beiting, Daniel P.; Scott, Phillip.
Artículo en Inglés | ARCA | ID: arc-37925

Documentos relacionados

  1. Variable gene expression and parasite load predict treatment outcome in cutaneous leishmaniasis.
  2. Platinossomose em felino doméstico no município de Pelotas, RS, Brasil
  3. Expression of the FUT2 gene and CD44 marker in patients with oral lesions
  4. Executive summary. Consensus document of GESIDA and SPNS (Spanish Secretariat for the National Plan on AIDS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)
  5. Transcriptional Analysis of Human Skin Lesions Identifies Tryptophan-2,3-Deoxygenase as a Restriction Factor for Cutaneous <i>Leishmania</i>.
  6. SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection.
  7. Orthotopic tumorgrafts in nude mice as a model to evaluate calcitriol effects in breast cancer
  8. Antileishmanial Effects of Synthetic <i>Eh</i>PIb Analogs Derived from the Entamoeba histolytica Lipopeptidephosphoglycan.
  9. Probability of false-negative results in microscopical detection of cutaneous leishmaniasis: more accurate screening by kDNA-PCR during epidemiological survey.
  10. Monitoring the response of patients with cutaneous leishmaniasis to treatment with pentamidine isethionate by quantitative real-time PCR, and identification of Leishmania parasites not responding to therapy.